Retinal vasculitis associated with Epstein-Barr virus infection in a young immunocompetent patient. First Colombian case report
Autor: | Juan Pablo Osorio-Lombana, Julia Recalde-Reyes, Santiago Sánchez-Pardo |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
medicine.medical_specialty
Epstein-Barr Virus Infections Visual acuity Retinitis Virus 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine medicine 030212 general & internal medicine Epstein–Barr virus infection General Environmental Science Retinal Vasculitis lcsh:R5-920 Retinal vasculitis business.industry Retinal detachment Retinal Acyclovir medicine.disease Dermatology chemistry 030221 ophthalmology & optometry Etiology General Earth and Planetary Sciences medicine.symptom business lcsh:Medicine (General) |
Zdroj: | Case Reports, Vol 5, Iss 2, Pp 139-146 (2019) |
ISSN: | 2462-8522 |
Popis: | Introduction: Epstein - Barr virus (EBV) infection is usually asymptomatic and persists throughout life. Eye involvement is rare, and even though there are some case reports, none of them comes from Colombia or Latin America.Case presentation: Immunocompetent young man with generalized unilateral retinal vasculitis, temporal and inferonasal bloodless vessels in the periphery, intraretinal hemorrhages, intense vitritis and retinal detachment. Epstein-Barr virus presence was determined using a polymerase chain reaction technique in vitreous humor. The patient recovered visual acuity with conventional antiviral oral treatment.Discussion: Eye involvement associated with Epstein-Barr virus is observed in immunocompromised patients, especially with HIV infection, where retinal involvement may occur. This case reports the presence of this pathology in an immunocompetent patient.Conclusions: Retinal vasculitis is a rare entity, frequently associated with immunocompromise. There is no diagnostic algorithm for this disease and eye involvement may be variable; there are no standard lines of treatment either. The evidence reported here explains the need for studies in selected patients showing visual acuity involvement without an established etiology. |
Databáze: | OpenAIRE |
Externí odkaz: |